Agenus Inc. (AGEN)

$6.15 1.65% $0.10 Healthcare

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 monospecific antibody that is in Phase 1 clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1777, an anti-TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody. In addition, the company develops INCAGN1876, an anti-GITR monospecific antibody; INCAGN1949, an anti-OX40 monospecific antibody; INCAGN2390, an anti-TIM-3 monospecific antibody; INCAGN2385, an anti-LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4; AGENT 797, an iNKT cells that is in Phase 1 clinical trial for solid tumors, multiple myeloma, and viral ARDS, as well as in clinical stage to treat hematological malignancies and multiple myeloma/B cells; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. Agenus Inc. operates under ASV, Agenus, AutoSynVax, EVAMPLIX, MiNK, PSV, PhosPhoSynVax, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Incyte Corporation, Merck Sharpe & Dohme, Recepta Biopharma SA, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

$132.67M

Dr. Garo H. Armen Ph.D.

441.00

Lexington, MA

Feb 04, 2000

-0.55

$-11.14

0.35

0.37

-139.99%

-0.59

-0.05

-0.54

0.84

0.37

-76.42%

122.08%

Similar stocks (10)

Viking Therapeutics, Inc.

VKTX

$67.45 4.65%
Uptrend

Madrigal Pharmaceuticals, Inc.

MDGL

$246.52 5.73%
Downtrend

TG Therapeutics, Inc.

TGTX

$25.76 2.02%
Uptrend

Edgewise Therapeutics, Inc.

EWTX

$29.77 56.11%
Uptrend

X4 Pharmaceuticals, Inc.

XFOR

$0.70 0.07%
Downtrend

PDS Biotechnology Corporation

PDSB

$3.20 4.24%
Downtrend

Leap Therapeutics, Inc.

LPTX

$2.83 -1.73%
Neutral

Marker Therapeutics, Inc.

MRKR

$2.88 3.97%
Downtrend

Pieris Pharmaceuticals, Inc.

PIRS

$16.45 1.79%
Uptrend

Galera Therapeutics, Inc.

GRTX

$0.08 1.89%
Downtrend

ETF Exposure (30)

Invesco DWA SmallCap Momentum ETF

DWAS

0.13%

$93.88 2.55%
Uptrend

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.13%

$42.04 0.12%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0.1%

$39.15 0.13%
Uptrend

iShares Micro-Cap ETF

IWC

0.02686%

$126.13 1.86%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$149.59 1.43%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0077409133%

$51.82 1.62%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00683%

$169.60 1.36%
Uptrend

iShares Russell 2000 ETF

IWM

0.00397%

$223.21 1.71%
Uptrend

WisdomTree BioRevolution Fund

WDNA

0.0024153%

$16.97 1.63%
Uptrend

ProShares Ultra Russell2000

UWM

0.001503924383510763%

$43.75 3.45%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00108%

$285.29 2.01%
Uptrend

ProShares UltraPro Russell2000

URTY

7.408691489680818e-4%

$53.74 5.20%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

6.678863e-4%

$66.18 1.63%
Uptrend

ProShares Hedge Replication ETF

HDG

6.283059664796254e-4%

$50.00 0.40%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

1.7e-4%

$125.11 1.67%
Uptrend

iShares Russell 3000 ETF

IWV

1.1e-4%

$325.24 1.63%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Health Care Index Fund

VHT

0%

$286.14 0.46%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$252.98 1.82%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$281.91 1.65%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0%

$207.70 1.97%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0%

$90.27 1.72%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.71 1.88%
Uptrend